Wednesday, April 24, 2024 4/24/2024

A Nurse-Community Health Worker-Family Partnership Model to Increase COVID-19 Testing in Urban Underserved and Vulnerable Communities

Award Number: P30DA011041
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

PROJECT SUMMARY/ABSTRACT New York City (NYC) is a global epicenter of the SARS-CoV2/COVID-19 pandemic, with 223,000 cases and more than 25,000 deaths. Neighborhood-level disparities in cases and deaths in NYC can be explained by socioeconomic and racial/ethnic characteristics, where Latinx and Black New Yorkers and those living in high poverty neighborhoods are 1.5 times more likely to test positive and more than twice as likely to die as a result of COVID-19. The community of Mott Haven is located in the South Bronx – one of the poorest congressional districts within the continental United States. Mott Haven is highly diverse (73% are Latinx and 24% are Black), and the COVID-19 mortality rate is higher than NYC as a whole – an epicenter within an epicenter. Yet, although Mott Haven is clearly a priority community for COVID-related prevention, detection, vaccination, and treatment initiatives, so far fewer than 2% of residents have been tested. COVID-19 secondary attack rates are highest in households, varying between 12 – 38%. This led us to propose a COVID-19 testing and mitigation intervention in public housing households in Mott Haven, which are characterized by crowding, intergenerational co-residence, and a high proportion of low wage “essential workers” who leave the home for work even during lockdown periods. We will evaluate the effectiveness of an innovative Nurse-Community Health Worker (CHW)-Family Partnership intervention designed to promote COVID-19 testing uptake, adoption of COVID-19 control measures, and mutual aid capacity at the household level. Our intervention is adapted from the Nurse-Family Partnership model, which has been shown to be effective and cost-effective in improving maternal and child health outcomes in high-poverty, racially- and ethnically-diverse communities. CHWs will provide culturally-appropriate support to families, addressing stigma, medical mistrust, and other common barriers to engagement in healthcare. We propose a 2-arm randomized controlled trial, in which 270 households (810 individuals) will be randomly assigned (2:1) to either the experimental group of families who will receive the Nurse-CHW-Family Partnership intervention and the offer of in-home testing and influenza vaccination, or the treatment-as-usual control group referred to free testing and flu vaccination located within walking distance. Participants in both arms will be assessed at baseline and monthly for 12 months. Findings from this study will provide an evidence-base to inform current and future public health initiatives related to COVID-19 mitigation in other high-risk settings. Sustainability will be addressed by building local capacity and expertise among participants, CHWs and CAB members, and partnering with them to develop the community’s best practices for COVID-19. Should it prove to be effective, our intervention can be tailored to increase testing and other COVID-19 control measures in other settings of vulnerability and disadvantage.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$19 )
2024	2023	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	004	26	2/22/2024	COMPETING CONTINUATION	$0
2024	2023	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	002	26	2/16/2024	COMPETING CONTINUATION	$563,272
2024	2022	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	001	25	2/16/2024	NON-COMPETING CONTINUATION	-$563,272
2024	2022	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Trans-NIH Research Support	000	25	12/11/2023	SUPPLEMENT FOR EXPANSION	$0
2024	2020	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Trans-NIH Research Support	003	23	2/21/2024	SUPPLEMENT FOR EXPANSION	-$19
														Subtotal = -$19

Issue Date FY: 2023 ( Subtotal = $1,506,082 )
2023	2023	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	003	26	6/23/2023	COMPETING CONTINUATION	$1,506,082
2023	2023	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	004	26	9/22/2023	COMPETING CONTINUATION	$0
2023	2022	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	002	25	6/16/2023	NON-COMPETING CONTINUATION	$0
2023	2022	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Trans-NIH Research Support	001	25	4/27/2023	SUPPLEMENT FOR EXPANSION	$0
2023	2022	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	000	25	11/30/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,506,082

Issue Date FY: 2022 ( Subtotal = $2,650,007 )
2022	2022	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Trans-NIH Research Support	005	25	6/23/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2022	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	001	25	3/24/2022	NON-COMPETING CONTINUATION	$147,573
2022	2022	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Trans-NIH Research Support	004	25	6/14/2022	SUPPLEMENT FOR EXPANSION	$1,174,281
2022	2022	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	000	25	1/21/2022	NON-COMPETING CONTINUATION	$1,328,153
2022	2020	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Trans-NIH Research Support	003	23	6/7/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2020	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Trans-NIH Research Support	006	23	7/26/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2020	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Trans-NIH Research Support	002	23	4/4/2022	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $2,650,007

Issue Date FY: 2021 ( Subtotal = $1,484,768 )
2021	2021	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	000	24	2/8/2021	NON-COMPETING CONTINUATION	$1,484,768
2021	2020	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Trans-NIH Research Support	001	23	8/27/2021	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $1,484,768

Issue Date FY: 2020 ( Subtotal = $5,119,692 )
2020	2020	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	002	23	9/11/2020	NON-COMPETING CONTINUATION	$0
2020	2020	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	001	23	1/17/2020	NON-COMPETING CONTINUATION	$1,476,627
2020	2020	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Trans-NIH Research Support	003	23	9/24/2020	SUPPLEMENT FOR EXPANSION	$3,643,065
2020	2019	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	000	22	12/6/2019	NON-COMPETING CONTINUATION	$0
														Subtotal = $5,119,692

Issue Date FY: 2019 ( Subtotal = $1,881,363 )
2019	2019	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	010	22	7/19/2019	SUPPLEMENT FOR EXPANSION	$0
2019	2019	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	005	22	5/20/2019	SUPPLEMENT FOR EXPANSION	$237,750
2019	2019	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	002	22	1/18/2019	NON-COMPETING CONTINUATION	$1,491,648
2019	2019	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	003	22	2/28/2019	NON-COMPETING CONTINUATION	$0
2019	2019	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	004	22	5/13/2019	SUPPLEMENT FOR EXPANSION	$151,965
2019	2018	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	001	21	10/20/2018	COMPETING CONTINUATION	$179,688
2019	2018	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	009	21	7/18/2019	COMPETING CONTINUATION	$44,996
2019	2017	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	008	20	7/18/2019	NON-COMPETING CONTINUATION	-$44,996
2019	2017	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	000	20	10/20/2018	NON-COMPETING CONTINUATION	-$179,688
2019	2016	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	007	19	6/21/2019	EXTENSION WITH OR WITHOUT FUNDS	$36,448
2019	2015	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	006	18	6/21/2019	NON-COMPETING CONTINUATION	-$36,448
														Subtotal = $1,881,363

Issue Date FY: 2018 ( Subtotal = $1,549,182 )
2018	2018	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	001	21	3/1/2018	COMPETING CONTINUATION	$1,549,182
2018	2017	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	000	20	2/23/2018	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,549,182

Issue Date FY: 2017 ( Subtotal = $1,354,410 )
2017	2017	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	000	20	12/29/2016	NON-COMPETING CONTINUATION	$1,218,969
2017	2017	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Drug Abuse and Addiction Research Programs	001	20	5/22/2017	NON-COMPETING CONTINUATION	$135,441
														Subtotal = $1,354,410

Issue Date FY: 2016 ( Subtotal = $1,332,543 )
2016	2016	NEW YORK UNIVERSITY	SPONSORED PGMS ACCOUNTING	NEW YORK	NY	10003	NEW YORK	USA	Drug Abuse and Addiction Research Programs	001	19	3/14/2016	EXTENSION WITH OR WITHOUT FUNDS	$121,139
2016	2016	NEW YORK UNIVERSITY	SPONSORED PGMS ACCOUNTING	NEW YORK	NY	10003	NEW YORK	USA	Drug Abuse and Addiction Research Programs	000	19	11/19/2015	EXTENSION WITH OR WITHOUT FUNDS	$1,211,404
														Subtotal = $1,332,543

Issue Date FY: 2015 ( Subtotal = $1,486,070 ) (Continued on the next page)
Grand Total All Awards = $34,723,813

Page 1 of 2 (97 items)12

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A Nurse-Community Health Worker-Family Partnership Model to Increase COVID-19 Testing in Urban Underserved and Vulnerable Communities

Award Number: P30DA011041

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer